Associated Papers
Clear Cell Adenocarcinoma of Urethra: Clinical and Pathologic Implications and Characterization of Molecular Aberrations.
Song B et al.
Cancer Research and Treatment, 2024
Evaluation of SNaPshot and Sanger sequencing for the detection of KRAS and NRAS mutations in a sample of Venezuelan patients with colorectal cancer.
Rodríguez-Carrascal D et al.
Ecancermedicalscience, 2024
Investigating genomic, proteomic, and post-transcriptional regulation profiles in colorectal cancer: a comparative study between primary tumors and associated metastases.
Ham-Karim H et al.
Cancer Cell International, 2023
Genetics of brain arteriovenous malformations and cerebral cavernous malformations.
Hongo H et al.
Journal of Human Genetics, 2023
Nosological and Theranostic Approach to Vascular Malformation through cfDNA NGS Liquid Biopsy.
Serio VB et al.
Journal of Clinical Medicine, 2022
Mucinous Histology, BRCA1/2 Mutations, and Elevated Tumor Mutational Burden in Colorectal Cancer.
Harpaz N et al.
Journal of Oncology, 2020
32377194 (PubMed )
Supplement: 6421205.f1.xlsx › TMB
A KRAS wild type mutational status confers a survival advantage in pancreatic ductal adenocarcinoma.
Windon AL et al.
Journal of Gastrointestinal Oncology, 2018
Next-generation sequencing adds value to the preoperative diagnosis of pancreatic cysts.
Rosenbaum MW et al.
Cancer Cytopathology, 2017
GNAS is frequently mutated in both low-grade and high-grade disseminated appendiceal mucinous neoplasms but does not affect survival.
Singhi AD et al.
Human Pathology, 2014
Select a paper to view details